Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franziska Büscheck

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate CancersChristoph Burdelski, Michael Fitzner, Claudia Hube-Magg, et al.
Annals of Surgical Oncology|February 29, 2020
MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive LymphocytesChristoph Fraune, Eike Burandt, Ronald Simon, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2022
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsDavid Dum, Ana Ocokoljic, Maximilian Lennartz, et al.
Scientific Reports|June 4, 2020
Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancersAndreas Marx, Aljoscha Schumann, Doris Höflmayer, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Diagnostic Pathology|May 3, 2019
SNW1 is a prognostic biomarker in prostate cancerDoris Höflmayer, Carla Willich, Claudia Hube-Magg, et al.
Urologic Oncology|April 4, 2020
Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancerTill Eichenauer, Luca Simmendinger, Martina Kluth, et al.
Oncotarget|March 23, 2019
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancerTill Eichenauer, Mohammad Hussein, Claudia Hube-Magg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 13, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancerFranziska Büscheck, Maciej Zub, Asmus Heumann, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate CancersChristoph Burdelski, Michael Fitzner, Claudia Hube-Magg, et al.
Annals of Surgical Oncology|February 29, 2020
MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive LymphocytesChristoph Fraune, Eike Burandt, Ronald Simon, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2022
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsDavid Dum, Ana Ocokoljic, Maximilian Lennartz, et al.
Scientific Reports|June 4, 2020
Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancersAndreas Marx, Aljoscha Schumann, Doris Höflmayer, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Diagnostic Pathology|May 3, 2019
SNW1 is a prognostic biomarker in prostate cancerDoris Höflmayer, Carla Willich, Claudia Hube-Magg, et al.
Urologic Oncology|April 4, 2020
Chromosomal deletion of 9p21 is linked to poor patient prognosis in papillary and clear cell kidney cancerTill Eichenauer, Luca Simmendinger, Martina Kluth, et al.
Oncotarget|March 23, 2019
A nuclear shift of GSK3β protein is an independent prognostic factor in prostate cancerTill Eichenauer, Mohammad Hussein, Claudia Hube-Magg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 13, 2019
The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancerFranziska Büscheck, Maciej Zub, Asmus Heumann, et al.
Pageof 12